Tongsheng Pharmaceutical (Jingmen) is an API manufacturer based in China. It holds 8 active US drug master files across a filed portfolio of 5 molecules.
| Molecule | Regulators | Docs |
|---|---|---|
| Trofinetide | US FDA | 3 |
| Carfilzomib | US FDA | 2 |
| Baricitinib | US FDA | 1 |
| Glycylglutamine | US FDA | 1 |
| Upadacitinib | US FDA | 1 |
Also appears on these molecule pages
Choose your molecules and target markets. Tongsheng Pharmaceutical (Jingmen) comes back tiered against every other supplier able to file there.
Start for free